Finzati - Logo
ARTL logo

Artelo Biosciences, Inc.

ARTL • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$2.64M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.17Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:41 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$2.64M
52W Range0.70 - 31.65
Beta-0.07
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.54
Current Ratio0.17
Quick Ratio0.17
Volume248.35K

Investment DNA

How strong this company looks for long-term investors

33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Weak liquidity · 0.17Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 6/21/2019
Industry: Biotechnology
P/B i: -2.26
Debt / Equity i: -0.54
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score4 / 20
Debt / Equity: -0.54
Current Ratio: 0.17
Quick Ratio: 0.17
Status: HighRisk

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

FAVORITO TAMARA A
Transaction: 07/17/2026
BUY
Change
+136
Price
$1.15
Filing
07/21/2026
Type
BUY
Kelly Steven
Transaction: 07/17/2026
BUY
Change
+136
Price
$1.15
Filing
07/21/2026
Type
BUY
EMANUELE ROBERT MARTIN
Transaction: 07/17/2026
BUY
Change
+136
Price
$1.15
Filing
07/21/2026
Type
BUY